ScholarIQanswers from OpenAlex & ORCID
Hans‐Henrik Parving
ResearcherPublications, citations & collaboration network
Hans‐Henrik Parving is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Hans‐Henrik Parving have?
ScholarIQindexed works
Hans‐Henrik Parving has 142 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Hans‐Henrik Parving have?
ScholarIQcitation count
Hans‐Henrik Parving has 26,342 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Hans‐Henrik Parving?
ScholarIQh-index
Hans‐Henrik Parving has an h-index of 61 in OpenAlex.
What is the i10-index of Hans‐Henrik Parving?
ScholarIQi10-index
Hans‐Henrik Parving has an i10-index of 109 in OpenAlex.
What is the OpenAlex record for Hans‐Henrik Parving?
ScholarIQopenalex
The OpenAlex for Hans‐Henrik Parving is on the source record.
What are the most-cited papers on Hans‐Henrik Parving?
ScholarIQmost cited works
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw, William F. Keane, William E. Mitch, Hans‐Henrik Parving, Giuseppe Remuzzi, Steven Snapinn, Zhonxin Zhang, Shahnaz Shahinfar
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
Peter Gæde, Pernille Vedel, Nicolai Balle Larsen, Gunnar V.H. Jensen, Hans‐Henrik Parving, Oluf Pedersen
Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Bengt Fellström, Alan G. Jardine, Roland E. Schmieder, Hallvard Holdaas, Kym M. Bannister, Jaap J. Beutler, Dong‐Wan Chae, Alejandro Chevaile, Stuart M. Cobbe, Carola Grönhagen‐Riska, José J. De Lima, R. Lins, Gert Mayer, Alan W. McMahon, Hans‐Henrik Parving, Giuseppe Remuzzi, Ola Samuelsson, S. Sonkodi, Gültekin Süleymanlar, Dimitrios Tsakiris, Vladimı́r Tesař, Vasil Todorov, Andrzej Więcek, Rudolf P. Wüthrich, Mattis Gottlow, Eva Johnsson, Faı̈ez Zannad
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study
Peter Gæde, Pernille Vedel, Hans‐Henrik Parving, Oluf Pedersen
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL
Dick de Zeeuw, Giuseppe Remuzzi, Hans‐Henrik Parving, William F. Keane, Zhongxin Zhang, Shahnaz Shahinfar, Steve Snapinn, Mark E. Cooper, William E. Mitch, Barry M. Brenner